Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone
Conditions
Hepatocellular Carcinoma (HCC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama, Birmingham, Alabama, United States
Mayo Clinic Arizona, Scottsdale, Arizona, United States
UC Irvine Medical Center, Orange, California, United States
Stanford University School of Medicine, Palo Alto, California, United States
University of Florida Shands Hospital, Gainesville, Florida, United States
University of Chicago, Chicago, Illinois, United States
University of Kansas Cancer Center, Kansas City, Kansas, United States
University of Louisville, Louisville, Kentucky, United States
Tulane University Health Sciences Center, New Orleans, Louisiana, United States
Mercy Medical Center, Inc., Baltimore, Maryland, United States
University of Minnesota, Minneapolis, Minnesota, United States
Kansas City Research Institute, Kansas City, Missouri, United States
Saint Louis University, St Louis, Missouri, United States
Washington University School of Medicine, St Louis, Missouri, United States
Billings Clinic, Billings, Montana, United States
Morristown Medical Center, Morristown, New Jersey, United States
St. Joseph's Hospital, Paterson, New Jersey, United States
Ohio State University, Columbus, Ohio, United States
Hospital of The University of Pennsylvania, Philadelphia, Pennsylvania, United States
Rhode Island Hospital, Providence, Rhode Island, United States
University of Tennessee Medical Center, Knoxville, Tennessee, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Benaroya Research Institute at Virginia Mason Hospital, Seattle, Washington, United States
Site No. 8409, Adelaide, Australia
Site No. 8412, Adelaide, Australia
Site No. 8403, Brisbane, Australia
Site No. 8401, Camperdown, Australia
Site No. 8407, Clayton, Australia
Site No. 8406, Concord, Australia
Site No. 8408, Fitzroy, Australia
Site No. 8405, Footscray, Australia
Site No. 8414, Heidelberg, Australia
Site No. 8411, Melbourne, Australia
Site No. 8402, Parkville, Australia
Site No. 8415, Perth, Australia
Site No. 8413, Sydney, Australia
University of Alberta Hospital, Edmonton, Alberta, Canada
Juravinski Cancer Centre, Hamilton, Ontario, Canada
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Site 8829, Changchun, China
Site No. 8821, Changsha, China
Site 8811, Fuzhou, China
Site 8820, Fuzhou, China
Site No.8816, Guangdong, China
Site 8827, Guangzhou, China
Site No.8828, Guangzhou, China
Site 8832, Hangzhou, China
Site No. 8802, Harbin, China
Site 8805, Hefei, China
Site No. 8808, Hefei, China
Site No.8815, Hefei, China
Site No. 8801, Nanjing, China
Site 8833, Qingdao, China
Site 8806, Shanghai, China
Site 8822, Shanghai, China
Site 8831, Shanghai, China
Site No. 8823, Xi'an, China
Site No. 8825, Xi'an, China
Site No. 9013, Bondy, France
Site No. 9005, Bordeaux, France
Site No. 9003, Créteil, France
Site No. 9006, Lille, France
Site 9012, Montpellier, France
Site No. 9008, Nantes, France
Site No. 9010, Nice, France
Site No. 9007, Paris, France
Site No. 9014, Paris, France
Site No. 9011, Rennes, France
Site No. 9001, Strasbourg, France
Site No. 9002, Toulouse, France
Site No. 9009, Vandœuvre-lès-Nancy, France
Site No. 9111, Aachen, Germany
Site No. 9113, Bonn, Germany
Site No. 9109, Dresden, Germany
Site No. 9108, Frankfurt am Main, Germany
Site No. 9106, Hamburg, Germany
Site No 9105, Hannover, Germany
Site No. 9112, Heidelberg, Germany
Site No. 9101, Mainz, Germany
Site No. 9102, München, Germany
Site No. 9104, Tübingen, Germany
Site No. 9110, Ulm, Germany
Site No. 8601, Hong Kong, Hong Kong
Site No. 9707, Afula, Israel
Site 9704, Haifa, Israel
Site No. 9702, Haifa, Israel
Site No. 9705, Jerusalem, Israel
Site No. 9703, Ramat Gan, Israel
Site No. 9706, Tel Aviv, Israel
Site No.9205, Modena, Italy
Site No. 9204, Naples, Italy
Site No. 9201, Palermo, Italy
Site No. 9203, Parma, Italy
Auckland City Hospital, Auckland, New Zealand, New Zealand
Site No. 8902, Christchurch, New Zealand
Site No. 9404, Coimbra, Portugal
Site No. 9405, Coimbra, Portugal
Site No. 9403, Lisbon, Portugal
Site No. 9401, Porto, Portugal
Site No. 9402, Porto, Portugal
Site 8702, Singapore, Singapore
Site 8703, Singapore, Singapore
Site No. 8701, Singapore, Singapore
Site No. 8208, Ansan, South Korea
Site No. 8211, Bucheon-si, South Korea
Site No. 8201, Busan, South Korea
Site 8216, Daegu, South Korea
Site No. 8207, Daegu, South Korea
Site No. 8213, Daegu, South Korea
Site No. 8220, Daegu, South Korea
Site 8224, Goyang, South Korea
Site No. 8221, Jinju, South Korea
Site No. 8218, Pusan, South Korea
Site No. 8222, Seongnam, South Korea
Site No. 8219, Seongnam-si, South Korea
Site No. 8202, Seoul, South Korea
Site No. 8203, Seoul, South Korea
Site No. 8205, Seoul, South Korea
Site No. 8209, Seoul, South Korea
Site No. 8212, Seoul, South Korea
Site No. 8215, Seoul, South Korea
Site No. 8223, Seoul, South Korea
Site No. 8210, Suwon, South Korea
Site No. 8217, Ulsan, South Korea
Site No. 8305, Kaohsiung City, Taiwan
Site No. 8307, Linkou District, Taiwan
Site No. 8306, Taichung, Taiwan
Site No. 8302, Tainan, Taiwan
Site No. 8301, Taipei, Taiwan
Site No. 8303, Taipei, Taiwan
Site No. 8502, Bangkok, Thailand
Site No. 8505, Bangkok, Thailand
Site No. 8503, Chiang Mai, Thailand
Site No. 8507, Hat Yai, Thailand
Site No. 8501, Khon Kaen, Thailand
Site No. 8506, Phitsanulok, Thailand
Site No. 9501, Birmingham, United Kingdom
Site No. 9505, Guildford, United Kingdom
Site No. 9503, Leeds, United Kingdom
Site No. 9502, London, United Kingdom
Site No. 9504, London, United Kingdom
Site No. 9506, London, United Kingdom
Study leads
SillaJen Medical
Study Director
SillaJen, Inc.